Pain

Lewis SA, DeMuro-Mercon CJ, Mordin MM, Farr J, Cole BJ, Mithoefer K, Engelhart L. Measuring pain and function in patients with articular cartilage repair. Poster presented at the 9th World Congress of the International Cartilage Repair Society; September 2010.

Abstract not available at this time

Masters E, Zlateva G, Harris NI. Real-world data for use in the real world: the pain paradigm. Ispor Connections. 2013;19(2):9-11.

No abstract available at this time.

Jensen MP, Martin SA, Cheung R. The Meaning of pain relief in a clinical trial. J Pain. 2005 Jun 1;6:400-6.

Data from 207 subjects in the early postoperative period in a controlled clinical trial were used to examine the factors that contribute to global ratings of satisfaction with pain relief. Prerecovery to postrecovery period change scores in pain intensity were not significantly associated with level of satisfaction with pain relief. However, endpoint pain intensity, average pain intensity, recall rating of maximum pain, and actual maximum pain during the immediate postoperative period all predicted relief satisfaction.

Cook SF, Bell T, Sweeney CT, Fehnel SE, Hollis KA. Impact on quality of life of constipation associated gi symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.

Abstract not available at this time

Dysktra LA, Granger AL. Interactions between the delta agonist SNC80, and the mu agonists, morphine, buprenorphine, and butorphanol in squirrel monkeys. Nida Res Monogr. 2000;180:65.

No abstract available at this time.

Rosen JB, Granger AL, Walker EA. Nalbuphine drug discriminations: effects of opioid peptide ctap. Poster presented at the 1st International Meeting of the Behavioral Pharmacology Society and European Behavioral Pharmacology Society; 1999.

Abstract not available at this time

Allen RM, Granger AL, Dysktra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist snc80 in a primate shock titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2000.

Abstract not available at this time

Allen RM, Granger AL, Dykstra LA. LY235959 potentiates the antinociceptive effects of morphine, l-methadone, levorphanol, butorphanol, and buprenorphine in a primate titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2001.

Abstract not available at this time

Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.

In opioid-dependent subjects, the low-efficacy mu agonist nalbuphine generally precipitates withdrawal or withdrawal-like stimuluseffects. To provide a more complete characterization of the discriminative stimulus effects of nalbuphine in opioid-treated subjects, seven White Carneux pigeons were treated daily with 10 mg/kg morphine i.m. and trained 6 h later to discriminate among 10 mg/kgmorphine, 1.0 mg/kg nalbuphine, and saline by responding on one of three different keys. When tested, morphine producedmorphine-key responding and nalbuphine produced nalbuphine-key responding.

Neighbors DM, Earnshaw SR, Bell L, Bhattacharyya SK. A model to perform economic evaluations of interventions for acute muscular low back pain. Poster presented at the 2000 ISPOR 5th Annual International Meeting; May 20, 2000. Arlington, VA.


Abstract not available at this time.

How Can We Help You?